NYSE:ACB - Aurora Cannabis Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $5.69
  • Forecasted Upside: 121.25 %
  • Number of Analysts: 7
  • Breakdown:
  • 2 Sell Ratings
  • 5 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$2.57
▼ -0.17 (-6.20%)

This chart shows the closing price for ACB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aurora Cannabis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACB

Analyst Price Target is $5.69
▲ +121.25% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Aurora Cannabis in the last 3 months. The average price target is $5.69, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 121.25% upside from the last price of $2.57.

This chart shows the closing price for ACB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 7 contributing investment analysts is to hold stock in Aurora Cannabis. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 11 hold ratings
  • 6 sell ratings
11/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 10 hold ratings
  • 4 sell ratings
2/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 4 sell ratings
5/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 4 sell ratings
8/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 3 sell ratings
11/25/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 2 sell ratings
2/23/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 2 sell ratings
4/24/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 2 sell ratings
5/24/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/16/2022CIBCLower Price TargetC$6.50 ➝ C$3.75Low
5/13/2022Cantor FitzgeraldLower Price TargetC$7.60 ➝ C$3.90High
2/11/2022Cantor FitzgeraldLower Price TargetC$10.75 ➝ C$7.60High
2/3/2022CIBCLower Price TargetC$9.25 ➝ C$6.50High
11/10/2021CIBCUpgradeUnderperform ➝ NeutralLow
10/1/2021Jefferies Financial GroupReiterated RatingHoldLow
9/29/2021CIBCLower Price TargetUnderperformC$7.00 ➝ C$6.50Low
9/28/2021Piper SandlerReiterated RatingHold$7.00High
9/28/2021MKM PartnersUpgradeSell ➝ Neutral$6.00 ➝ $7.00High
9/28/2021Needham & Company LLCReiterated RatingSellHigh
9/23/2021CIBCLower Price TargetUnderperformC$8.00 ➝ C$7.00Low
9/17/2021Cantor FitzgeraldLower Price TargetNeutralC$12.00 ➝ C$8.30Low
9/3/2021Jefferies Financial GroupUpgradeUnderperform ➝ Hold$7.49 ➝ $6.78Medium
7/23/2021Atb Cap MarketsReiterated RatingUnderperformHigh
5/17/2021CIBCLower Price TargetNeutral ➝ UnderperformerC$15.00 ➝ C$9.00N/A
5/14/2021Needham & Company LLCInitiated CoverageSellLow
5/14/2021Cantor FitzgeraldLower Price TargetNeutral$11.25 ➝ $9.00High
5/14/2021BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$9.00 ➝ $8.00High
5/11/2021CIBCDowngradeNeutral ➝ Sector Underperform$15.00 ➝ $9.00Low
4/28/2021Bank of AmericaInitiated CoverageNeutralHigh
4/5/2021CIBCLower Price TargetNeutral$18.50 ➝ $15.00Low
2/16/2021CIBCBoost Price TargetNeutral$17.00 ➝ $18.50Low
2/12/2021MKM PartnersDowngradeNeutral ➝ SellLow
2/12/2021Needham & Company LLCDowngradeHold ➝ UnderperformLow
2/12/2021Cantor FitzgeraldBoost Price TargetNeutral$17.00 ➝ $18.00Low
2/12/2021DesjardinsDowngradeHold ➝ SellLow
2/8/2021CIBCBoost Price TargetNeutral$15.00 ➝ $17.00High
2/5/2021Cantor FitzgeraldBoost Price TargetNeutral$16.00 ➝ $17.00Low
1/25/2021Cantor FitzgeraldBoost Price TargetNeutral$12.00 ➝ $16.00Medium
1/4/2021Jefferies Financial GroupReiterated RatingUnderperform$4.59N/A
12/17/2020BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$9.00Low
11/16/2020Atb Cap MarketsUpgradeUnderperform ➝ Sector PerformLow
11/16/2020Jefferies Financial GroupDowngradeHold ➝ Underperform$5.56 ➝ $3.75Low
11/11/2020Stifel NicolausDowngradeHold ➝ SellN/A
11/10/2020CIBCBoost Price TargetNeutral$12.00 ➝ $15.00Low
11/9/2020Atb Cap MarketsDowngradeSector Perform ➝ UnderperformMedium
11/9/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral$13.00 ➝ $12.00High
10/28/2020Stifel NicolausLower Price TargetHold$10.50 ➝ $3.60Medium
10/27/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral$18.00 ➝ $7.00High
9/24/2020CIBCLower Price TargetNeutral$20.00 ➝ $12.00Low
9/23/2020CowenReiterated RatingHold$10.00Low
9/23/2020Cantor FitzgeraldBoost Price TargetOverweight$17.50 ➝ $18.00High
9/23/2020Needham & Company LLCReiterated RatingHoldHigh
9/23/2020Piper SandlerLower Price TargetNeutral$10.00 ➝ $8.00High
9/21/2020Jefferies Financial GroupUpgradeUnderperform ➝ HoldHigh
9/9/2020Stifel NicolausLower Price TargetPositive ➝ Hold$16.00 ➝ $10.50High
9/9/2020Cantor FitzgeraldLower Price TargetOverweight$29.00 ➝ $17.50Low
9/8/2020Needham & Company LLCReiterated RatingHoldHigh
9/8/2020LADENBURG THALM/SH SHDowngradeBuy ➝ Neutral$9.00High
8/18/2020CIBCLower Price TargetNeutral$24.00 ➝ $20.00Low
6/24/2020Cantor FitzgeraldBoost Price TargetOverweight$27.00 ➝ $29.00Medium
6/24/2020Stifel NicolausUpgradeSell ➝ Hold$6.20 ➝ $17.50Low
6/23/2020Needham & Company LLCInitiated CoverageHoldLow
5/22/2020CIBCBoost Price TargetNeutral$14.00 ➝ $24.00Low
5/22/2020Jefferies Financial GroupDowngradeHold ➝ Underperform$12.00 ➝ $14.00Medium
5/21/2020Cantor FitzgeraldBoost Price TargetMarket Perform ➝ Overweight$22.00 ➝ $27.00High
5/19/2020MKM PartnersInitiated CoverageHold$18.00High
5/18/2020CIBCReiterated RatingBuy ➝ Market Perform$27.00 ➝ $14.00High
5/15/2020Pi FinancialReiterated RatingNeutralHigh
5/15/2020DesjardinsUpgradeBuyHigh
5/15/2020Piper SandlerUpgradeUnderweight ➝ Neutral$12.00 ➝ $10.00High
5/13/2020Cantor FitzgeraldBoost Price TargetOverweight$22.00High
5/12/2020Eight CapitalReiterated RatingHold$11.00High
4/13/2020Cantor FitzgeraldLower Price TargetOverweight$45.60 ➝ $33.00Low
4/13/2020Needham & Company LLCReiterated RatingHoldHigh
2/27/2020Bryan, Garnier & CoDowngradeNeutral ➝ SellLow
2/25/2020Needham & Company LLCInitiated CoverageHold$18.00High
2/24/2020Cantor FitzgeraldBoost Price TargetOverweight$45.00 ➝ $45.60Low
2/24/2020CowenDowngradeOutperform ➝ Market Perform$72.00 ➝ $30.00Medium
2/16/2020Pi FinancialReiterated RatingHold$24.00High
2/16/2020CIBCReiterated RatingHold$27.00High
2/14/2020MKM PartnersUpgradeSell ➝ NeutralLow
2/10/2020CIBCReiterated RatingHold$30.00High
2/7/2020Pi FinancialDowngradeHold$24.00High
2/7/2020Eight CapitalDowngradeBuy ➝ NeutralLow
2/7/2020Cantor FitzgeraldLower Price TargetOverweight$60.00 ➝ $45.00Low
2/7/2020Compass PointLower Price TargetNeutral$60.00 ➝ $24.00High
2/6/2020Jefferies Financial GroupDowngradeHoldHigh
1/10/2020Piper Jaffray CompaniesDowngradeNeutral ➝ Underweight$36.00 ➝ $12.00Low
1/10/2020Bank of AmericaDowngradeNeutral ➝ Underperform$12.00High
1/10/2020Piper SandlerDowngradeOverweight ➝ Neutral$36.00 ➝ $12.00High
12/31/2019Jefferies Financial GroupDowngradeHold$36.00High
12/23/2019MKM PartnersReiterated RatingSell$36.00 ➝ $24.00Medium
12/23/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$36.00Medium
11/26/2019Cantor FitzgeraldReiterated RatingBuy$52.80Low
11/15/2019MKM PartnersDowngradeHold$42.00 ➝ $36.00High
11/15/2019Cantor FitzgeraldUpgradeNeutral ➝ Overweight$61.20 ➝ $70.20High
11/15/2019Piper Jaffray CompaniesLower Price TargetNeutral$48.00 ➝ $36.00High
11/4/2019Cantor FitzgeraldInitiated CoverageNeutral$61.20High
10/22/2019Piper Jaffray CompaniesLower Price TargetNeutral$84.00 ➝ $48.00Medium
10/15/2019Pi FinancialSet Price TargetBuy$84.00High
10/11/2019Jefferies Financial GroupSet Price TargetBuy$84.00Low
9/24/2019CIBCInitiated CoverageNeutral$84.00High
9/20/2019MKM PartnersDowngradeSellLow
9/19/2019MKM PartnersInitiated CoverageBuy$60.00Medium
9/13/2019Piper Jaffray CompaniesSet Price TargetHold$84.00High
9/12/2019Compass PointSet Price TargetHold$96.00High
9/12/2019Stifel NicolausReiterated RatingHold ➝ Sell$84.00 ➝ $60.00High
8/12/2019Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$84.00Low
7/18/2019Bank of AmericaDowngradeBuy ➝ Neutral$87.60High
7/17/2019LADENBURG THALM/SH SHInitiated CoverageBuy ➝ Buy$108.00Medium
7/8/2019Compass PointInitiated CoverageNeutral ➝ NeutralMedium
6/5/2019Stifel NicolausInitiated CoverageHold ➝ HoldMedium
4/25/2019DesjardinsInitiated CoverageBuy ➝ Buy$108.84Low
4/17/2019Bank of AmericaInitiated CoverageBuy ➝ Buy$132.00Medium
3/13/2019GMP SecuritiesUpgradeHold ➝ BuyHigh
3/5/2019CowenInitiated CoverageOutperformHigh
2/25/2019Jefferies Financial GroupInitiated CoverageBuy ➝ BuyHigh
2/12/2019GMP SecuritiesReiterated RatingHold$114.00High
(Data available from 5/25/2017 forward)

News Sentiment Rating

-0.18 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 9 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
10/27/2021
  • 2 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/26/2021
  • 2 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/26/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
1/25/2022
  • 3 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
2/24/2022
  • 2 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/26/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
4/25/2022
  • 1 very positive mentions
  • 8 positive mentions
  • 11 negative mentions
  • 1 very negative mentions
5/25/2022

Current Sentiment

  • 1 very positive mentions
  • 8 positive mentions
  • 11 negative mentions
  • 1 very negative mentions
Aurora Cannabis logo
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Read More

Today's Range

Now: $2.57
Low: $2.54
High: $2.76

50 Day Range

MA: $3.32
Low: $2.29
High: $4.46

52 Week Range

Now: $2.57
Low: $2.20
High: $10.64

Volume

5,457,889 shs

Average Volume

6,962,681 shs

Market Capitalization

$576.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.86

Frequently Asked Questions

What sell-side analysts currently cover shares of Aurora Cannabis?

The following Wall Street analysts have issued research reports on Aurora Cannabis in the last twelve months: Atb Cap Markets, Cantor Fitzgerald, CIBC, Jefferies Financial Group Inc., MKM Partners, Needham & Company LLC, Piper Sandler, and Zacks Investment Research.
View the latest analyst ratings for ACB.

What is the current price target for Aurora Cannabis?

0 Wall Street analysts have set twelve-month price targets for Aurora Cannabis in the last year. Their average twelve-month price target is $5.69, suggesting a possible upside of 121.2%.
View the latest price targets for ACB.

What is the current consensus analyst rating for Aurora Cannabis?

Aurora Cannabis currently has 2 sell ratings and 5 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ACB, but not buy more shares or sell existing shares.
View the latest ratings for ACB.

How do I contact Aurora Cannabis' investor relations team?

Aurora Cannabis' physical mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company's listed phone number is (855) 279-4652 and its investor relations email address is [email protected] The official website for Aurora Cannabis is auroramj.com. Learn More about contacing Aurora Cannabis investor relations.